skip to Main Content

16th Medicines for Europe – Biosimilar Medicines Conference

16th Medicines for Europe – Biosimilar Medicines Conference

Patient Workshop

London, 25th April

 

 

 

Biosimilar medicines are an essential part of healthcare provision in Europe today. Europe will continue to play a leading role in shaping a sustainable regulatory framework regionally and globally to promote greater access to essential therapies for auto-immune diseases and cancer. The Biosimilar Medicines Group has pioneered this development and supports greater global cooperation for future development.

It was a great opportunity: WFIP was one of the five invited patient advocacy organizations and was asked to wrap up and close the conference with closing remarks.

 

 

Here you can read the final report.

 

Back To Top